On Tuesday, Arcellx Inc (NASDAQ: ACLX) opened lower -4.02% from the last session, before settling in for the closing price of $67.36. Price fluctuations for ACLX have ranged from $47.88 to $107.37 over the past 52 weeks.
Here's Your FREE Report on the #1 Small-Cap Uranium Stock of '24.
Small-cap Uranium stocks are booming in 2024! The company we're about to show you is the ONLY small-cap stock in the space that benefits from ALL aspects of the global Uranium industry with none of the risks of running a mine. Smart investors will not be hesitating on this one!
Get the FREE Report with all the details here.
Sponsored
Company’s average yearly earnings per share was noted -9.24% at the time writing. With a float of $40.66 million, this company’s outstanding shares have now reached $53.99 million.
In an organization with 130 employees, it is important to assess its efficiency. In terms of profitability, gross margin is 98.21%, operating margin of -44.55%, and the pretax margin is -25.18%.
Arcellx Inc (ACLX) Insider and Institutional Ownership
A key investor’s attitude towards the stock of the Biotechnology industry is another important factor to consider. The insider ownership of Arcellx Inc is 24.82%, while institutional ownership is 81.59%. The most recent insider transaction that took place on Jan 14 ’25, was worth 98,801. In this transaction Director of this company sold 1,500 shares at a rate of $65.87, taking the stock ownership to the 0 shares. Before that another transaction happened on Jan 07 ’25, when Company’s CHIEF MEDICAL OFFICER sold 4,230 for $75.53, making the entire transaction worth $319,485. This insider now owns 28,638 shares in total.
Arcellx Inc (ACLX) Latest Financial update
Wall Street market experts anticipate that the next fiscal year will bring earnings of -0.7 per share during the current fiscal year.
According to the Wall Street analysts, stocks earnings will be around -9.24% per share during the next fiscal year.
Arcellx Inc (NASDAQ: ACLX) Trading Performance Indicators
Check out the current performance indicators for Arcellx Inc (ACLX). In the past quarter, the stock posted a quick ratio of 4.29. In addition, a publicly-traded company’s price to sales ratio for the trailing twelve months stands at 22.44. Likewise, its price to free cash flow for the trailing twelve months is 976.52.
For the trailing twelve months, Company’s Diluted EPS (Earnings per Share) is -0.75, a number that is poised to hit -0.55 in the next quarter and is forecasted to reach -2.28 in one year’s time.
Technical Analysis of Arcellx Inc (ACLX)
Let’s dig in a bit further. During the last 5-days, its volume was 0.86 million. That was better than the volume of 0.76 million it reported in year-ago period. As of the previous 9 days, the stock’s Stochastic %D was 9.16%. Additionally, its Average True Range was 4.34.
During the past 100 days, Arcellx Inc’s (ACLX) raw stochastic average was set at 1.27%, which indicates a significant decrease from 1.54% during the past two weeks. Based on volatility metrics of the stock, it showed a historical volatility of 46.52% in the past 14 days, which was lower than the 53.08% volatility it showed in the past 100 days.
At the time of writing, stock’s 50-day Moving Average is $84.61, while its 200-day Moving Average is $69.34. However, in the short run, Arcellx Inc’s stock first resistance to watch stands at $67.58. Second resistance stands at $70.51. The third major resistance level sits at $72.10. If the price goes on to break the first support level at $63.06, it is likely to go to the next support level at $61.47. The third support level lies at $58.54 if the price breaches the second support level.
Arcellx Inc (NASDAQ: ACLX) Key Stats
There are currently 54,075K shares outstanding in the company with a market cap of 3.50 billion. Presently, the company’s annual sales total 110,320 K according to its annual income of -70,690 K. Last quarter, the company’s sales amounted to 26,030 K and its income totaled -25,870 K.